ArticleBMC pregnancy and childbirth2025
A prediction model of preterm birth in singleton pregnancy after assisted reproduction therapy.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectivePreterm birth is a major global health issue, with higher rates observed in pregnancies following assisted reproductive technology (ART). This study aimed to develop and validate via the validation set a prediction model for preterm birth in singleton pregnancies following ART, by identifying key clinical and ART-related risk factors.
methodsThis retrospective study included 268 women who underwent ART and delivered singleton Live births at Sun Yat-sen Memorial Hospital between 2013 and 2021. Data on demographic characteristics, medical history, ART-related factors, pregnancy complications, and delivery outcomes were extracted from medical records. The study cohort was randomly divided into a training set (160 participants) and an internal validation set (108 participants). The training set was used to identify predictors and construct a nomogram using multivariable logistic regression. The model's performance was evaluated through discrimination (area under the curve, AUC), calibration (calibration curves), and clinical usefulness (decision curve analysis). The relationship between cervical length and gestational age was also assessed using restricted cubic splines.
resultsThe total preterm birth rate was 23.5% (63/268). Independent risk factors for preterm birth in singleton pregnancies after ART included the number of embryos implanted (OR = 3.54, 95% CI: 1.29-9.69, p = 0.014), gestational hypertensive disease (GHD) (OR = 3.07, 95% CI: 1.36-6.93, p = 0.007), premature rupture of membranes (PROM) (OR = 4.70, 95% CI: 1.90-11.61, p < 0.001), polycystic ovary syndrome (PCOS) (OR = 2.27, 95% CI: 1.04-4.93, p = 0.039), and intrauterine adhesion (IA) (OR = 3.32, 95% CI: 0.67-16.59, p = 0.043). The nomogram developed from these factors demonstrated acceptable discrimination (AUC = 0.77 in the training set, AUC = 0.71 in the validation set) and calibration in both sets. Decision curve analysis showed that the model provided net benefits across a wide range of threshold probabilities (0.00 to 0.83). The analysis of cervical length indicated significant differences between the preterm and full-term groups, with a higher reduction rate in cervical length observed in the preterm group after 16 weeks of gestation.
conclusionsThe prediction model developed in this study is effective for predicting preterm birth risk in ART pregnancies. This model can help clinicians identify high-risk pregnancies early and implement targeted interventions. Cervical length monitoring may be a useful tool in predicting preterm birth, especially after the second trimester.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.